Linio Biotech to attend the 44th annual JP Morgan Healthcare Conference
San Francisco, January 2026 — Linio Biotech's CEO, Karita Reijonsaari, will be attending the 44th annual JP Morgan Healthcare Conference, an annual event bringing together leaders from across the healthcare, life sciences, and investment communities.
During the conference week, Karita will participate in the Dermatology Summit and hold a series of meetings with strategic partners and investors. These discussions will focus on Linio Biotech’s technology platform, achievements to date, and the company’s longer-term development and commercialization plans.
“The JP Morgan Healthcare Conference brings together the key decision-makers shaping the future of healthcare,” said Karita Reijonsaari, CEO of Linio Biotech. “This is an important opportunity for us to share our vision for the future of medical aesthetics that move beyond traditional fillers towards regenerative solutions, and to engage with partners who share our long-term perspective.”
Meetings during the conference week will center on strategic collaboration opportunities, investment discussions, and alignment with partners across dermatology, aesthetics, and regenerative medicine as Linio Biotech advances its pipeline toward broader international markets.
Linio Biotech to attend the 44th annual JP Morgan Healthcare Conference
San Francisco, January 2026 — Linio Biotech's CEO, Karita Reijonsaari, will be attending the 44th annual JP Morgan Healthcare Conference, an annual event bringing together leaders from across the healthcare, life sciences, and investment communities.
During the conference week, Karita will participate in the Dermatology Summit and hold a series of meetings with strategic partners and investors. These discussions will focus on Linio Biotech’s technology platform, achievements to date, and the company’s longer-term development and commercialization plans.
“The JP Morgan Healthcare Conference brings together the key decision-makers shaping the future of healthcare,” said Karita Reijonsaari, CEO of Linio Biotech. “This is an important opportunity for us to share our vision for the future of medical aesthetics that move beyond traditional fillers towards regenerative solutions, and to engage with partners who share our long-term perspective.”
Meetings during the conference week will center on strategic collaboration opportunities, investment discussions, and alignment with partners across dermatology, aesthetics, and regenerative medicine as Linio Biotech advances its pipeline toward broader international markets.